Vudalimab - Research Grade Biosimilar

SKU: orb1237908

Description

Vudalimab - Research Grade Biosimilar

Research Area

,Other

Key Properties

• Antibody Type: Primary Antibody
• Clonality: Recombinant
• Isotype: Bispecific ,IgG1,Kappa;Kappa
• Immunogen: Humanized / CTLA4, PDCD1
• Target: CTLA4
• Purity: > 95%
• Purification: > 95%
• Conjugation: Unconjugated

Storage & Handling

• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks). Store at -20 °C 12 months. Store at -80°C long term.
• Buffer/Preservatives: PBS buffer pH 7.5
• Concentration: batch dependent
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

ANTI-PD-1/ANTI-CTLA-4 XMAB20717, ANTI-PD1/CTLA4 BISPECIFIC ANTIBODY XMAB20717, IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)) AND ANTI-(HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODY, BISPECIFIC PD-1 X CTLA-4 DUAL CHECKPOINT INHIBITOR XMAB20717 VUDALIMAB, VUDALIMAB [INN], XMAB20717, XMAB-20717, CD; GSE; GRD4; ALPS5; CD152; CTLA-4; IDDM12; CELIAC3

Quick Database Links

Gene Symbol

CTLA4

UniProt

P16410

RefSeq:P16410